NDC 82584-609

ZIOPTAN

Tafluprost

ZIOPTAN is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Thea Pharma Inc.. The primary component is Tafluprost.

• Product ID: 82584-609_ec1dfc7a-46bb-7414-e053-2995a90a9929
• NDC: 82584-609
• Product Type: Human Prescription Drug
• Proprietary Name: ZIOPTAN
• Generic Name: Tafluprost
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2022-10-28
• Marketing Category: NDA /
• Application Number: NDA202514
• Labeler Name: Thea Pharma Inc.
• Substance Name: TAFLUPROST
• Active Ingredient Strength: 0 mg/mL
• Pharm Classes: Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 82584-609-30

3 POUCH in 1 CARTON (82584-609-30) > 10 VIAL, SINGLE-USE in 1 POUCH (82584-609-01) > .3 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2022-10-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ZIOPTAN" or generic name "Tafluprost"

NDC	Brand Name	Generic Name
17478-609	ZIOPTAN	tafluprost
82584-609	ZIOPTAN	Tafluprost
0781-6184	Tafluprost	Tafluprost
65302-062	Tafluprost	Tafluprost
66993-429	Tafluprost Ophthalmic	tafluprost